Approval of Unaudited Financial Results For The Quarter Ended September 30, 2025

Revenue Growth 20pctEbitda Margin CompressionNegative Operating CashflowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.8%Reaction day

₹83.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%+3.9% vs market

Specialty Chemicals peers, median of 85sector+0.7%+4.1% vs sector

On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 4.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.8+0.9+3.9+0.7+4.1

Next day

+2.3+0.8+1.5+0.4+2.0

+3.6+0.7+2.9+0.4+3.2

+3.6+1.3+2.3-0.2+3.8

+0.8+0.5+0.3-1.2+2.0

-2.4+0.4-2.8-1.8-0.6

-4.4-1.5-2.9-2.3-2.1

15d

-2.4-2.4+0.0-4.2+1.8

-3.6-4.4+0.8-5.2+1.6

-15.4-7.2-8.2-8.9-6.5

-10.2-5.0-5.2-8.6-1.6

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kemistar Corporation's board approved its Q2 FY26 (ended Sept 30, 2025) results on Nov 11, 2025. On a consolidated basis, revenue from operations jumped to ₹857.84 lakhs from ₹377.20 lakhs in Q2 FY25, a sharp ~127% YoY rise, driven mainly by subsidiary K.P. International. Half-yearly consolidated revenue grew to ₹1,143.19 lakhs (vs ₹738.71 lakhs, +55%). However, profitability collapsed — consolidated Q2 profit fell to just ₹0.93 lakh (vs ₹12.59 lakhs) and H1 profit dropped to ₹12.09 lakhs (vs ₹25.79 lakhs, -53%), as cost of purchases scaled up steeply. Standalone revenue was weak at ₹115.09 lakhs (vs ₹123.58 lakhs) and standalone H1 profit fell to ₹8.58 lakhs (vs ₹15.55 lakhs). Auditor N.S. Nanavati & Co. issued a clean, unmodified limited review on both sets of results.

Likely market impact

Strong top-line growth from the subsidiary is a positive signal, but the steep margin compression and plunging profits show the company is not yet converting scale into earnings. Shareholders may see the revenue beat as encouraging while remaining cautious until profit margins recover; near-term stock reaction will depend on whether Q3 shows operating leverage.